- Research works
- 111 ▼ 12% vs 2013–17
- Citations
- 6.3k 56.7 per fractional work
- Top-10% rate
- 20.4% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: International Drug Development Institute (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 16.4×. Every wedge is a field page.
- Mathematics 16.4×
- Economics, Econometrics and Finance 4.6×
- Decision Sciences 3.5×
- Medicine 2.2×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Dentistry 1.6×
- Nursing 0.8×
- Immunology and Microbiology 0.7×
- Neuroscience 0.7×
- Computer Science 0.4×
- Materials Science 0.4×
- Business, Management and Accounting 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.2×
- Health Professions 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Physics and Astronomy 0.0×
Who are the top researchers at International Drug Development Institute (Belgium)?
Ranked on the composite score, Marc Buyse and Everardo D. Saad lead among researchers whose main affiliation is International Drug Development Institute (Belgium).
- 1 Marc Buyse Belgium · #11,432 worldwide 895 citations · 100 works
- 2 Everardo D. Saad Belgium · #273,040 worldwide 81 citations · 22 works
Which keywords describe research at International Drug Development Institute (Belgium)?
By fractional works in all years, weighted toward what it does more of than the world: Bayesian Methods, Biomarkers, Adaptive Designs, False Discovery Rate, Chemotherapy, Quality of Life, Molecular Subtypes and Precision Medicine.
- Tumor Markers
- Treatment Response
- Breast Tumours
- Chemotherapy-Induced Peripheral Neuropathy
- PRISMA Statement
- Quality Assessment
- Meta-Analysis
- Metastatic Breast Cancer
- Cancer Genomics
- Breast Cancer
- Propensity Score
- Survival Analysis
- Fluorouracil
- Clinical Trials
- Neoadjuvant Therapy
- Health Utility Measures
- Precision Medicine
- Quality of Life
- False Discovery Rate
- Biomarkers
- Bayesian Methods
- Adaptive Designs
- Chemotherapy
- Molecular Subtypes
- Cost-effectiveness Analysis
- Clinical Practice Guidelines
- Cetuximab
- Targeted Therapy
- KRAS Mutations
- Causal Inference
- Radiotherapy
- Genomic Instability
- Gene Expression
- Mutational Signatures
- Diagnostic Accuracy
- Adjuvant Chemotherapy
- Publication Bias
- Taxanes
- Prognostic Markers
- Preoperative Chemoradiotherapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Bayesian Methods16▲ 241×2 topics
- Biomarkers16▲ 23×8 topics
- Adaptive Designs14▲ 529×1 topic
- False Discovery Rate14▲ 529×1 topic
- Chemotherapy11▲ 14×19 topics
- Quality of Life11▲ 7.1×8 topics
- Molecular Subtypes8▲ 80×3 topics
- Precision Medicine8▲ 22×5 topics
- Cost-effectiveness Analysis6▲ 74×1 topic
- Health Utility Measures6▲ 74×1 topic
- Clinical Practice Guidelines6▲ 10×7 topics
- Neoadjuvant Therapy6▲ 24×5 topics
- Cetuximab5▲ 59×2 topics
- Clinical Trials5▲ 7.8×9 topics
- Targeted Therapy5▲ 22×4 topics
- Fluorouracil5▲ 140×1 topic
- KRAS Mutations5▲ 140×1 topic
- Survival Analysis5▲ 17×5 topics
- Causal Inference5▲ 126×1 topic
- Propensity Score5▲ 289×1 topic
- Radiotherapy5▲ 11×8 topics
- Breast Cancer4▲ 13×9 topics
- Genomic Instability4▲ 28×2 topics
- Cancer Genomics4▲ 65×1 topic
- Gene Expression4▲ 5.7×8 topics
- Metastatic Breast Cancer4▲ 53×2 topics
- Mutational Signatures4▲ 65×1 topic
- Meta-Analysis4▲ 6.1×3 topics
- Diagnostic Accuracy4▲ 43×2 topics
- Quality Assessment4▲ 16×3 topics
- Adjuvant Chemotherapy3▲ 40×2 topics
- PRISMA Statement3▲ 127×1 topic
- Publication Bias3▲ 56×1 topic
- Chemotherapy-Induced Peripheral Neuropathy3▲ 51×1 topic
- Taxanes3▲ 51×1 topic
- Breast Tumours3▲ 47×1 topic
- Prognostic Markers3▲ 24×2 topics
- Treatment Response3▲ 47×1 topic
- Preoperative Chemoradiotherapy2▲ 28×2 topics
- Tumor Markers2▲ 27×2 topics
Which research topics does International Drug Development Institute (Belgium) publish most on?
By volume in 2022–2025: Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life, Colorectal Cancer Treatments and Studies and Statistical Methods and Inference.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Statistical Methods in Clinical Trials Statistics and Probability 2 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 3 Colorectal Cancer Treatments and Studies Oncology 1 works
- 4 Statistical Methods and Inference Statistics and Probability 1 works
- 5 Cancer Genomics and Diagnostics Cancer Research 1 works
- 6 Advanced Causal Inference Techniques Statistics and Probability 1 works
- 7 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
- 8 Global Cancer Incidence and Screening Oncology 0 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 10 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has International Drug Development Institute (Belgium)'s research output changed?
Output in 2018–2022 was 12% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Brussels
- Vrije Universiteit Brussel
- Université Libre de Bruxelles
- Cliniques Universitaires Saint-Luc
- Erasmus Hospital
- European Commission
- UCLouvain Saint-Louis Brussels
- European Union of Medical Specialists
- European Union
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.